Insulet Past Earnings Performance
Past criteria checks 5/6
Insulet has been growing earnings at an average annual rate of 70.3%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 20% per year. Insulet's return on equity is 39.6%, and it has net margins of 21.1%.
Key information
70.3%
Earnings growth rate
68.5%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 20.0% |
Return on equity | 39.6% |
Net Margin | 21.1% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Additional Considerations Required While Assessing Insulet's (NASDAQ:PODD) Strong Earnings
Aug 16A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Jul 15Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023
Jun 11We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)
May 26At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?
May 12Is Insulet (NASDAQ:PODD) A Risky Investment?
Apr 29Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Apr 14Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)
Mar 31Insulet: Insulating Patients, Investors Still Have To Wait
Mar 28Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price
Feb 19Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?
Jan 22Insulet: An Interesting, Yet Expensive, Story
Jan 10Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jan 09Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Dec 27Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Nov 14Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Oct 31We Think Insulet (NASDAQ:PODD) Is Taking Some Risk With Its Debt
Oct 01Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?
Sep 16Estimating The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Aug 14Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Jul 31Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jun 18Getting In Cheap On Insulet Corporation (NASDAQ:PODD) Might Be Difficult
May 22Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger
Apr 30Here's Why Insulet (NASDAQ:PODD) Has A Meaningful Debt Burden
Jan 24Insulet (NASDAQ:PODD) Shareholders Will Want The ROCE Trajectory To Continue
Dec 28Insulet: An Overpriced Play In The Medical Space
Oct 18Insulet (NASDAQ:PODD) Has A Pretty Healthy Balance Sheet
Oct 02Revenue & Expenses Breakdown
How Insulet makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 1,873 | 395 | 788 | 204 |
31 Mar 24 | 1,781 | 234 | 745 | 205 |
31 Dec 23 | 1,697 | 206 | 708 | 205 |
30 Sep 23 | 1,557 | 120 | 694 | 213 |
30 Jun 23 | 1,465 | 63 | 653 | 200 |
31 Mar 23 | 1,368 | 1 | 622 | 187 |
31 Dec 22 | 1,305 | 5 | 588 | 180 |
30 Sep 22 | 1,243 | 17 | 538 | 173 |
30 Jun 22 | 1,178 | 35 | 515 | 165 |
31 Mar 22 | 1,142 | 45 | 484 | 163 |
31 Dec 21 | 1,099 | 17 | 466 | 160 |
30 Sep 21 | 1,037 | -29 | 474 | 157 |
30 Jun 21 | 996 | -30 | 446 | 158 |
31 Mar 21 | 959 | 9 | 411 | 152 |
31 Dec 20 | 904 | 7 | 384 | 147 |
30 Sep 20 | 868 | 29 | 334 | 144 |
30 Jun 20 | 826 | 18 | 320 | 137 |
31 Mar 20 | 777 | 5 | 315 | 135 |
31 Dec 19 | 738 | 12 | 298 | 132 |
30 Sep 19 | 694 | 17 | 270 | 126 |
30 Jun 19 | 653 | 17 | 268 | 117 |
31 Mar 19 | 600 | 14 | 251 | 103 |
31 Dec 18 | 564 | 3 | 248 | 95 |
30 Sep 18 | 529 | -13 | 249 | 80 |
30 Jun 18 | 500 | -17 | 227 | 78 |
31 Mar 18 | 486 | -23 | 218 | 77 |
31 Dec 17 | 464 | -27 | 209 | 76 |
30 Sep 17 | 437 | -29 | 191 | 72 |
30 Jun 17 | 410 | -30 | 179 | 65 |
31 Mar 17 | 387 | -26 | 168 | 60 |
31 Dec 16 | 367 | -27 | 166 | 56 |
30 Sep 16 | 347 | -34 | 159 | 53 |
30 Jun 16 | 324 | -49 | 156 | 49 |
31 Mar 16 | 297 | -62 | 149 | 48 |
31 Dec 15 | 264 | -62 | 139 | 43 |
30 Sep 15 | 253 | -51 | 129 | 38 |
30 Jun 15 | 256 | -44 | 126 | 35 |
31 Mar 15 | 268 | -56 | 128 | 29 |
31 Dec 14 | 231 | -48 | 108 | 28 |
30 Sep 14 | 285 | -49 | 112 | 27 |
30 Jun 14 | 271 | -59 | 115 | 26 |
31 Mar 14 | 259 | -40 | 108 | 24 |
31 Dec 13 | 247 | -45 | 117 | 22 |
30 Sep 13 | 236 | -53 | 116 | 21 |
Quality Earnings: PODD has high quality earnings.
Growing Profit Margin: PODD's current net profit margins (21.1%) are higher than last year (4.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PODD's earnings have grown significantly by 70.3% per year over the past 5 years.
Accelerating Growth: PODD's earnings growth over the past year (528.5%) exceeds its 5-year average (70.3% per year).
Earnings vs Industry: PODD earnings growth over the past year (528.5%) exceeded the Medical Equipment industry 5.5%.
Return on Equity
High ROE: Whilst PODD's Return on Equity (39.59%) is high, this metric is skewed due to their high level of debt.